全文获取类型
收费全文 | 2107506篇 |
免费 | 155325篇 |
国内免费 | 5029篇 |
专业分类
耳鼻咽喉 | 29310篇 |
儿科学 | 66273篇 |
妇产科学 | 60743篇 |
基础医学 | 298547篇 |
口腔科学 | 58444篇 |
临床医学 | 187052篇 |
内科学 | 410898篇 |
皮肤病学 | 47269篇 |
神经病学 | 172762篇 |
特种医学 | 81387篇 |
外国民族医学 | 626篇 |
外科学 | 316977篇 |
综合类 | 53153篇 |
现状与发展 | 4篇 |
一般理论 | 726篇 |
预防医学 | 164441篇 |
眼科学 | 49213篇 |
药学 | 150809篇 |
61篇 | |
中国医学 | 4728篇 |
肿瘤学 | 114437篇 |
出版年
2018年 | 22686篇 |
2017年 | 17420篇 |
2016年 | 19746篇 |
2015年 | 22378篇 |
2014年 | 31709篇 |
2013年 | 47357篇 |
2012年 | 64103篇 |
2011年 | 67580篇 |
2010年 | 39696篇 |
2009年 | 37792篇 |
2008年 | 62574篇 |
2007年 | 66816篇 |
2006年 | 67164篇 |
2005年 | 65300篇 |
2004年 | 62724篇 |
2003年 | 60101篇 |
2002年 | 58018篇 |
2001年 | 97232篇 |
2000年 | 99482篇 |
1999年 | 83186篇 |
1998年 | 24290篇 |
1997年 | 21954篇 |
1996年 | 21877篇 |
1995年 | 20739篇 |
1994年 | 19178篇 |
1993年 | 17983篇 |
1992年 | 64949篇 |
1991年 | 62504篇 |
1990年 | 60445篇 |
1989年 | 57793篇 |
1988年 | 53593篇 |
1987年 | 52473篇 |
1986年 | 49415篇 |
1985年 | 47401篇 |
1984年 | 36400篇 |
1983年 | 30860篇 |
1982年 | 19234篇 |
1981年 | 17376篇 |
1979年 | 34156篇 |
1978年 | 24309篇 |
1977年 | 20298篇 |
1976年 | 18945篇 |
1975年 | 19888篇 |
1974年 | 24382篇 |
1973年 | 23487篇 |
1972年 | 22222篇 |
1971年 | 20363篇 |
1970年 | 19418篇 |
1969年 | 18387篇 |
1968年 | 16962篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Deverick J Anderson Luke F Chen David J Weber Rebekah W Moehring Sarah S Lewis Patricia F Triplett Michael Blocker Paul Becherer J Conrad Schwab Lauren P Knelson Yuliya Lokhnygina William A Rutalo Hajimori Kanamori Marina F Gergen Daniel J Sexton for the CDC Prevention Epicenters Program 《中华医院感染学杂志》2018,(12)
中文:背景患者入院后可从不当消毒的环境表面获得多药耐药菌和艰难梭菌。本文确定了3种强化的终末消毒(入住同一病房的两名患者之间的消毒)策略,对感染耐甲氧西林金黄色葡萄球菌(MRSA)、耐万古霉素肠球菌(VRE)、艰难梭菌(CD)和多重耐药不动杆菌的影响。方法本文在美国东南部的9家医院开展了一项务实的、集群-随机、交叉研究。凡曾有感染或定植目标细菌感染患者居住过的病房,患者出院后随机采取4种消毒策略中的一种方法进行终末消毒:对照(季胺盐类消毒剂消毒,但凡遇到CD采用含氯消毒剂);UV(季胺盐类+UV-C消毒,但凡遇到CD采用含氯消毒剂+UV-C);含氯消毒剂;含氯消毒剂+UV-C。凡入住目标病房的患者被列为暴露人群。这4种终末消毒方法分别在每家医院连续实施7个月的周期。本文随机设计这几种消毒策略在每家医院内的实施顺序(1:1:1:1)。主要产出的结果是,观察暴露患者中目标细菌的感染的发生或定植情况,以及ITT人群中暴露患者CD感染发生率。本研究ClinicalTrials.gov注册编号:NCT01579370。结果共有31 226名患者暴露,其中21 395(69%)符合标准,包括4 916名对照组,5 178名UV组,5 438名含氯消毒剂组,以及5 863名含氯消毒剂+UV组。在对照组中,22 426个暴露日中有115名患者发生目标细菌的感染(51.3/10000暴露日)。在标准清洁策略的基础上增加UV消毒的暴露患者,其目标细菌感染的发生率明显较低(n=76;33.9/10 000暴露日;RR:0.70,95%CI:0.50~0.988;P=0.036)。含氯消毒剂组(n=101;41.6/10 000暴露日;RR:0.85,95%CI:0.69~1.04;P=0.116),或含氯消毒剂+UV组患者(n=131;45.6/10 000暴露日;RR:0.91,95%CI:0.76~1.09;P=0.303)的目标细菌的感染率,其差异无统计学意义。同样,在含氯消毒剂的基础上增加UV消毒,暴露患者中CD感染率也没有发生改变((n=38 vs 36;30.4 vs 31.6/10 000暴露日;RR:1.0,95%CI:0.57-1.75;P=0.997)。解释污染的医疗机构环境是获得病原微生物的重要来源;强化终末消毒可以降低这一风险。 相似文献
92.
93.
94.
95.
96.
Aaron Yarlas Martha Bayliss Joseph C. Cappelleri Stephen Maher Andrew G. Bushmakin Lea Ann Chen Alireza Manuchehri Paul Healey 《Quality of life research》2018,27(2):273-290
Purpose
To conduct a systematic literature review of the reliability, construct validity, and responsiveness of the SF-36® Health Survey (SF-36) in patients with ulcerative colitis (UC).Methods
We performed a systematic search of electronic medical databases to identify published peer-reviewed studies which reported scores from the eight scales and/or two summary measures of the SF-36 collected from adult patients with UC. Study findings relevant to reliability, construct validity, and responsiveness were reviewed.Results
Data were extracted and summarized from 43 articles meeting inclusion criteria. Convergent validity was supported by findings that 83% (197/236) of correlations between SF-36 scales and measures of disease symptoms, disease activity, and functioning exceeded the prespecified threshold (r ≥ |0.40|). Known-groups validity was supported by findings of clinically meaningful differences in SF-36 scores between subgroups of patients when classified by disease activity (i.e., active versus inactive), symptom status, and comorbidity status. Responsiveness was supported by findings of clinically meaningful changes in SF-36 scores following treatment in non-comparative trials, and by meaningfully larger improvements in SF-36 scores in treatment arms relative to controls in randomized controlled trials. The sole study of SF-36 reliability found evidence supporting internal consistency (Cronbach’s α ≥ 0.70) for all SF-36 scales and test–retest reliability (intraclass correlation coefficient ≥0.70) for six of eight scales.Conclusions
Evidence from this systematic literature review indicates that the SF-36 is reliable, valid, and responsive when used with UC patients, supporting the inclusion of the SF-36 as an endpoint in clinical trials for this patient population.97.
Purpose
Most computerized adaptive testing (CAT) applications in patient-reported outcomes (PRO) measurement to date are reliability-centric, with a primary objective of maximizing measurement efficiency. A key concern and a potential threat to validity is that, when left unconstrained, individual CAT administrations could have items with systematically different attributes, e.g., sub-domain coverage. This paper aims to provide a solution to the problem from an optimal test design framework using the shadow-test approach to CAT.Methods
Following the approach, a case study was conducted using the PROMIS® (Patient-Reported Outcomes Measurement Information System) fatigue item bank both with empirical and simulated response data. Comparisons between CAT administrations without and with the enforcement of content and item pool usage constraints were examined.Results
The unconstrained CAT exhibited a high degree of variation in items selected from different substrata of the item bank. Contrastingly, the shadow-test approach delivered CAT administrations conforming to all specifications with a minimal loss in measurement efficiency.Conclusions
The optimal test design and shadow-test approach to CAT provide a flexible framework for solving complex test-assembly problems with better control of their domain coverage than for the conventional use of CAT in PRO measurement. Applications in a wide array of PRO domains are expected to lead to more controlled and balanced use of CAT in the field.98.
Purpose
Measurement invariance issues should be considered during test construction. In this paper, we provide a conceptual overview of measurement invariance and describe how the concept is implemented in several different statistical approaches. Typical applications look for invariance over things such as mode of administration (paper and pencil vs. computer based), language/translation, age, time, and gender, to cite just a few examples. To the extent that the relationships between items and constructs are stable/invariant, we can be more confident in score interpretations.Methods
A series of simulated examples are reported which highlight different kinds of non-invariance, the impact it can have, and the effect of appropriately modeling a lack of invariance. One example focuses on the longitudinal context, where measurement invariance is critical to understanding trends over time. Software syntax is provided to help researchers apply these models with their own data.Results
The simulation studies demonstrate the negative impact an erroneous assumption of invariance may have on scores and substantive conclusions drawn from naively analyzing those scores.Conclusions
Measurement invariance implies that the links between the items and the construct of interest are invariant over some domain, grouping, or classification. Examining a new or existing test for measurement invariance should be part of any test construction/implementation plan. In addition to reviewing implications of the simulation study results, we also provide a discussion of the limitations of current approaches and areas in need of additional research.99.
Swann Arp Adams Catherine L. Rohweder Jennifer Leeman Daniela B. Friedman Ziya Gizlice Robin C. Vanderpool Natoshia Askelson Alicia Best Susan A. Flocke Karen Glanz Linda K. Ko Michelle Kegler 《Journal of community health》2018,43(6):1044-1052
While colorectal cancer (CRC) screening rates have been increasing in the general population, rates are considerably lower in Federally Qualified Health Centers (FQHCs), which serve a large proportion of uninsured and medically vulnerable patients. Efforts to screen eligible patients must be accelerated if we are to reach the national screening goal of 80% by 2018 and beyond. To inform this work, we conducted a survey of key informants at FQHCs in eight states to determine which evidence-based interventions (EBIs) to promote CRC screening are currently being used, and which implementation strategies are being employed to ensure that the interventions are executed as intended. One hundred and forty-eight FQHCs were invited to participate in the study, and 56 completed surveys were received for a response rate of 38%. Results demonstrated that provider reminder and recall systems were the most commonly used EBIs (44.6%) while the most commonly used implementation strategy was the identification of barriers (84.0%). The mean number of EBIs that were fully implemented at the centers was 2.4 (range 0–7) out of seven. Almost one-quarter of respondents indicated that their FQHCs were not using any EBIs to increase CRC screening. Full implementation of EBIs was correlated with higher CRC screening rates. These findings identify gaps as well as the preferences and needs of FQHCs in selecting and implementing EBIs for CRC screening. 相似文献
100.